Dr. Buynak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
454 College Ave
Valparaiso, IN 46383Phone+1 219-462-7173Fax+1 219-462-7504
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1995 - 1998
Harvard Medical SchoolClass of 1995
Certifications & Licensure
IL State Medical License 2005 - 2026
TX State Medical License 2023 - 2026
IN State Medical License 1998 - 2025
OH State Medical License 2023 - 2025
AL State Medical License 2023 - 2024
WI State Medical License 2023 - 2023
FL State Medical License 2012 - 2016- American Board of Internal Medicine Internal Medicine
- Join now to see all
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2014-2016
Clinical Trials
- A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain Start of enrollment: 2014 Jul 01
- Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
- Effects of the GOLO for Life System Diet With and Without GOLO Release Supplement on Glycemic Control and Insulin Resistance Start of enrollment: 2019 Oct 01
Publications & Presentations
PubMed
- 1 citationsShort article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.Stefan Zeuzem, Parvez S. Mantry, Vicente Soriano, Robert Buynak, Jean-François Dufour
European Journal of Gastroenterology & Hepatology. 2016-08-01 - Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.Donald M. Jensen, Tarik Asselah, Douglas T. Dieterich, Graham R. Foster, Mark S. Sulkowski
Annals of Hepatology. 2016-05-01 - 42 citationsLong-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open...Robert Buynak, Stephen A. Rappaport, Kevin Rod, Pierre Arsenault, Fabian Heisig
Clinical Therapeutics. 2015-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
